skip navigationU S P T O SealUnited States Patent and Trademark Office AOTW logo
Home|Site Index|Search|Guides|Contacts|eBusiness|eBiz alerts|News|Help
Assignments on the Web > Patent Query
Patent Assignment Abstract of Title
NOTE:Results display only for issued patents and published applications. For pending or abandoned applications please consult USPTO staff.

Total Assignments: 3
Patent #:
Issue Dt:
07/02/2013
Application #:
12678120
Filing Dt:
08/24/2010
Publication #:
Pub Dt:
02/10/2011
Inventors:
Oana Cociorva, Yasumichi Fukuda, Yasushi Kohno, Kyoko Okada, Ayako Nakamura, Bei Li et al
Title:
SPIROCYCLIC AMINOQUINOLNES AS GSK-3 INHIBITORS
Assignment: 1
Reel/Frame:
024526/0147Recorded: 06/11/2010Pages: 4
Conveyance:
ASSIGNMENT OF ASSIGNORS INTEREST (SEE DOCUMENT FOR DETAILS).
Assignors:
Exec Dt:
05/27/2010
Exec Dt:
05/21/2010
Exec Dt:
05/25/2010
Assignee:
11025 NORTH TORREY PINES ROAD
SUITE 120
LA JOLLA, CALIFORNIA 92037
Correspondent:
MEGHA BHUMRALKAR
555 SOUTH FLOWER STREET
50TH FLOOR
LOS ANGELES, CA 90071
Assignment: 2
Reel/Frame:
024945/0275Recorded: 08/18/2010Pages: 3
Conveyance:
ASSIGNMENT OF ASSIGNORS INTEREST (SEE DOCUMENT FOR DETAILS).
Assignor:
Exec Dt:
06/02/2010
Assignee:
5, KANDA SURUGADAI 2-CHOME,
CHIODA-KU
TOKYO, JAPAN 101-8311
Correspondent:
JONES DAY
222 EAST 41ST STREET
SANDRA GENUA
NEW YORK, NY 10017-6702
Assignment: 3
Reel/Frame:
024854/0103Recorded: 08/18/2010Pages: 5
Conveyance:
ASSIGNMENT OF ASSIGNORS INTEREST (SEE DOCUMENT FOR DETAILS).
Assignors:
Exec Dt:
06/16/2010
Exec Dt:
06/16/2010
Exec Dt:
06/23/2010
Exec Dt:
06/16/2010
Exec Dt:
06/17/2010
Exec Dt:
06/16/2010
Exec Dt:
06/16/2010
Assignee:
5, KANDA SURUGADAI 2-CHOME,
CHIODA-KU
TOKYO, JAPAN 101-8311
Correspondent:
JONES DAY
222 EAST 41ST STREET
SANDRA GENUA
NEW YORK, NY 10017-6702

Search Results as of: 05/05/2024 02:03 PM
If you have any comments or questions concerning the data displayed, contact PRD / Assignments at 571-272-3350. v.2.6
Web interface last modified: August 25, 2017 v.2.6
| .HOME | INDEX| SEARCH | eBUSINESS | CONTACT US | PRIVACY STATEMENT